OpGen Q4 Revenues Up 18 Percent on Product Sales | GenomeWeb

NEW YORK (GenomeWeb) – OpGen reported after the opening of the market on Wednesday an 18 percent increase in its fourth quarter revenues.

For the three months ended Dec. 31, the Gaithersburg, Maryland-based infectious disease testing and analysis firm reported $1.3 million in revenues, up from $1.1 million in the prior-year Q4.

Product sales increased 220 percent to $1.3 million, attributable to the firm's acquisition of AdvanDx in July.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.